Skip to main content
Top
Published in: World Journal of Surgery 6/2010

01-06-2010

Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma

Authors: Tracy-Ann Moo, Julie McGill, John Allendorf, James Lee, Thomas Fahey III, Rasa Zarnegar

Published in: World Journal of Surgery | Issue 6/2010

Login to get access

Abstract

Background

Although the role of prophylactic central neck lymph node dissection (CNLD) in the treatment of papillary thyroid carcinoma (PTC) is controversial, many surgeons perform routine prophylactic CNLD. The present study compares local recurrence rates in PTC patients undergoing total thyroidectomy with and without prophylactic CNLD.

Materials and Methods

A retrospective review of 206 patients undergoing thyroidectomy for PTC was conducted at two tertiary referral centers. Of these, 81 patients had total thyroidectomy for PTC and a follow-up between 2 and 9 years with a mean of 3.1 years. Of these 81 patients, 45 underwent routine prophylactic CNLD and 36 did not. For those two groups, demographics, clinical and pathologic findings, radioactive iodine (RAI) treatment, and the incidence of recurrence were compared. Univariate statistical analysis was performed.

Results

There was no significant difference in age, gender, multifocality, or extrathyroidal extension for the two groups. Patients with CNLD had an average tumor size of 1.4 cm versus 2 cm in the group without CNLD (p < 0.05). Patients who underwent CNLD had an average of 8 nodes removed, and positive nodes were found in 33%. Patients with CNLD received a higher dose of RAI, 102.7 mCi versus 66.3 mCi (p < 0.05). The incidence of positive nodes correlated with an increased RAI dose (r = 0.55). Rates of parathyroid removal and autotransplantation were higher in the CNLD group, 36 and 16% in the CNLD group versus 22 and 3% in the group without CNLD (p = 0.4 and p = 0.07). Rates of temporary hypocalcemia were higher in the CNLD group (31 versus 5%; p = 0.001), however rates of permanent hypocalcemia were similar, 1/35 in the no CNLD group versus 0/45 in the CNLD group (p = 0.4). There was a higher recurrence rate among patients without CNLD 6/36 (16.7%) versus 2/45 (4.4%), although this difference was not statistically significant (p = 0.13).

Conclusions

Routine CNLD as an adjunct to total thyroidectomy identifies positive nodes in over 30% of patients with PTC. The discovery of positive nodes is associated with higher doses of RAI for postoperative ablation, and there is a trend toward decreased recurrence in patients undergoing CNLD.
Literature
1.
go back to reference Rotstein L (2009) The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. J Surg Oncol 99:186–188CrossRefPubMed Rotstein L (2009) The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. J Surg Oncol 99:186–188CrossRefPubMed
2.
go back to reference Mazzaferri E, Jhiang S (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428CrossRefPubMed Mazzaferri E, Jhiang S (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428CrossRefPubMed
3.
go back to reference DeGroot L, Kaplan E, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424CrossRefPubMed DeGroot L, Kaplan E, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424CrossRefPubMed
4.
go back to reference Sato N, Oyamatsu M, Koyama Y et al (1998) Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151–155CrossRefPubMed Sato N, Oyamatsu M, Koyama Y et al (1998) Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151–155CrossRefPubMed
5.
go back to reference Scheumann G, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–567 (discussion 567–558)CrossRefPubMed Scheumann G, Gimm O, Wegener G et al (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559–567 (discussion 567–558)CrossRefPubMed
6.
go back to reference Shah J, Loree T, Dharker D et al (1992) Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164:658–661CrossRefPubMed Shah J, Loree T, Dharker D et al (1992) Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164:658–661CrossRefPubMed
7.
go back to reference Lundgren C, Hall P, Dickman P et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRefPubMed Lundgren C, Hall P, Dickman P et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRefPubMed
8.
go back to reference Tisell L, Nilsson B, Mölne J et al (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20:854–859CrossRefPubMed Tisell L, Nilsson B, Mölne J et al (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20:854–859CrossRefPubMed
9.
go back to reference Cooper D, Doherty G, Haugen B et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142CrossRefPubMed Cooper D, Doherty G, Haugen B et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142CrossRefPubMed
10.
go back to reference Hughes C, Shaha A, Shah J et al (1996) Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18:127–132CrossRefPubMed Hughes C, Shaha A, Shah J et al (1996) Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18:127–132CrossRefPubMed
11.
go back to reference Sawka A, Brierley J, Tsang R et al (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 37:457–480CrossRefPubMed Sawka A, Brierley J, Tsang R et al (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 37:457–480CrossRefPubMed
12.
go back to reference White M, Gauger P, Doherty G (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904CrossRefPubMed White M, Gauger P, Doherty G (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904CrossRefPubMed
13.
go back to reference Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729CrossRefPubMed Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729CrossRefPubMed
14.
go back to reference Hay I, Bergstralh E, Grant C et al (1999) Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 126:1173–1181 (discussion 1181–1172)CrossRefPubMed Hay I, Bergstralh E, Grant C et al (1999) Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 126:1173–1181 (discussion 1181–1172)CrossRefPubMed
15.
go back to reference Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167CrossRefPubMed Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167CrossRefPubMed
16.
go back to reference Hackshaw A, Harmer C, Mallick U et al (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92:28–38CrossRefPubMed Hackshaw A, Harmer C, Mallick U et al (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92:28–38CrossRefPubMed
17.
go back to reference Dionigi G, Dionigi R, Bartalena L et al (2006) Surgery of lymph nodes in papillary thyroid cancer. Expert Rev Anticancer Ther 6:1217–1229CrossRefPubMed Dionigi G, Dionigi R, Bartalena L et al (2006) Surgery of lymph nodes in papillary thyroid cancer. Expert Rev Anticancer Ther 6:1217–1229CrossRefPubMed
18.
go back to reference Palestini N, Borasi A, Cestino L et al (2008) Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck’s Arch Surg 393:693–698CrossRef Palestini N, Borasi A, Cestino L et al (2008) Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck’s Arch Surg 393:693–698CrossRef
Metadata
Title
Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma
Authors
Tracy-Ann Moo
Julie McGill
John Allendorf
James Lee
Thomas Fahey III
Rasa Zarnegar
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 6/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0418-3

Other articles of this Issue 6/2010

World Journal of Surgery 6/2010 Go to the issue